editorial
-
Health
Common sweeteners may alter gut bacteria, Cambridge study finds
Laboratory research from the University of Cambridge found that several commercially used sweeteners directly affected gut bacteria, with one sweetener…
Read More » -
Health
Salsa classes ease depressive symptoms in young adults, Oxford trial finds
An eight-week salsa dance programme reduced depressive symptoms, social anxiety and improved daily happiness in young adults with mild to…
Read More » -
Health
Infections tied to higher risk of brain and mental health conditions for up to two years, study finds
A study of more than one million matched patient pairs found that adults hospitalised with serious infections were more likely…
Read More » -
Health
Home visits within 24 hours of discharge may cut emergency hospital returns, study finds
A University of Manchester study of more than 63,000 patients found that prompt follow-up by community health teams after hospital…
Read More » -
Pharma
European Commission approves first GLP-1 weight loss pill for obesity treatment
Novo Nordisk’s once-daily Wegovy pill becomes the first GLP-1 receptor agonist tablet approved in the European Union for weight management.…
Read More » -
Technology
AI safely supports prostate cancer diagnosis in NHS study
Artificial intelligence helped improve consistency in prostate cancer diagnosis, shortened reporting times in some centres and reduced the need for…
Read More » -
Pharma
Novartis to acquire Myricx Bio to strengthen next-generation cancer therapy pipeline
The UK biotechnology company’s novel antibody-drug conjugate platform and two preclinical cancer therapy candidates will expand Novartis’ oncology research portfolio.…
Read More » -
Pharma
EU approves Enhertu as first tumour-agnostic HER2-targeted therapy for metastatic solid tumours
The approval allows the drug to be used across multiple HER2-positive cancers, regardless of where the tumour originated, for patients…
Read More » -
Health
Oxford launches paediatric oncology research programme to speed up childhood cancer treatments
The University of Oxford has launched a new paediatric oncology research programme, supported by the Little Princess Trust and the…
Read More » -
Pharma
New treatment for alopecia areata in adults and adolescents moves closer to EU approval after CHMP recommendation
Positive opinion is based on Phase III trial results showing significant scalp hair regrowth, with a final European Commission decision…
Read More »
